Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin on Myocardial Perfusion During Cardiac Surgery
NCT05464966Completed
- Sponsor
- Yangzhou University
- Start
- Jun 2022
- Primary completion
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in Myocardial injury, sponsored by Yangzhou University. Primary endpoint: Coronary sinus blood flow spectrum. Started Jun 2022; status: completed.
02
Drugs
human insulin
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT05464966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05464966.